Virtual screening and molecular dynamics simulations provide insight into repurposing drugs against SARS-CoV-2 variants Spike protein/ACE2 interface

D Pirolli, B Righino, C Camponeschi, F Ria… - Scientific Reports, 2023 - nature.com
After over two years of living with Covid-19 and hundreds of million cases worldwide there is
still an unmet need to find proper treatments for the novel coronavirus, due also to the rapid …

In silico discovery of small molecule modulators targeting the Achilles' heel of SARS-CoV-2 spike protein

Q Wang, F Meng, Y Xie, W Wang, Y Meng… - ACS Central …, 2023 - ACS Publications
The spike protein of SARS-CoV-2 has been a promising target for developing vaccines and
therapeutics due to its crucial role in the viral entry process. Previously reported cryogenic …

Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

J Cerneckis, H Cai, Y Shi - Signal Transduction and Targeted Therapy, 2024 - nature.com
The induced pluripotent stem cell (iPSC) technology has transformed in vitro research and
holds great promise to advance regenerative medicine. iPSCs have the capacity for an …

The Apolipoprotein E neutralizing antibody inhibits SARS‐CoV‐2 infection by blocking cellular entry of lipoviral particles

Q Cui, AV Jeyachandran, G Garcia jr, C Qin… - MedComm, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is the causal agent for
coronavirus disease 2019 (COVID‐19). Although vaccines have helped to prevent …

Directed Differentiation of Neurons from Human iPSCs for Modeling Neurological Disorders

C Wang, J Cerneckis, Y Shi - Cerebral Cortex Development: Methods and …, 2024 - Springer
Human-induced pluripotent stem cell (hiPSC) technology has enabled comprehensive
human cell-based disease modeling in vitro. Due to limited accessibility of primary human …